Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Jupiter Wellness Inc (JUPW)

Jupiter Wellness Inc (JUPW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 35,308
  • Shares Outstanding, K 22,927
  • Annual Sales, $ 1,066 K
  • Annual Income, $ -6,289 K
  • 60-Month Beta N/A
  • Price/Sales 15.10
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade JUPW with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4900 unch
on 09/17/21
1.9400 -23.20%
on 09/07/21
-0.1300 (-8.02%)
since 08/17/21
3-Month
1.4900 unch
on 09/17/21
4.9300 -69.78%
on 07/15/21
-2.9300 (-66.29%)
since 06/17/21

Most Recent Stories

More News
Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els

Pro Golf Hall of Fame Legend Extends Endorsement of CaniSun Suncare Products

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Submitted a Pre-IND Meeting Request with the US FDA for its Proposed Clinical Program of JW-100 as a Treatment for Mild to Moderate Eczema

Following receipt of a Pre-Assignment number from the FDA Jupiter Wellness requests Pre-IND meeting

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Applies for IND number from the US Food and Drug Administration

Following positive results from the JW-100 investigator initiated trials for Eczema, Jupiter Wellness to commence US FDA program

JUPW : 1.4900 (-3.25%)
Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW).

NEW YORK, NY / ACCESSWIRE / July 26, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW).

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Closes $32.5 Million Underwritten Public Offering of Common Stock and Warrants

JUPITER, FL / ACCESSWIRE / July 26, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the closing of an underwritten public offering (the "Offering") of 11,066,258 shares (the...

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Prices $32.5 Million Underwritten Public Offering of Common Stock and Warrants

JUPITER, FL / ACCESSWIRE / July 21, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the pricing of an underwritten public offering (the "Offering") of 11,066,258 shares (the...

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Announces Multi-Year Distribution Agreement with Rigour International for Expansion in Asia

JUPITER, FL / ACCESSWIRE / July 19, 2021 / , Inc. , today announced a multi-year agreement with Rigour International LLC as the exclusive authorized distributor of Jupiter Wellness Products within the...

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Announces Appointment of Dr. Andy Goren to Scientific Advisory Board

JUPITER, FL / ACCESSWIRE / July 15, 2021 / , Inc. , today announced that Dr Andy Goren has been appointed to its Scientific Advisory Board.

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Announces initiation of Head-to-Head Trial Comparing JW-100 and Eucrisa(R) for the Treatment of Mild-to-Moderate Eczema

JUPITER, FL / ACCESSWIRE / July 13, 2021 / , Inc. , today announced a head-to-head trial comparing JW-100 lotion with Eucrisa crisaborole ointment 2% for the treatment of patients with mild to moderate...

JUPW : 1.4900 (-3.25%)
Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis

*Photo-Therapy in a tub

JUPW : 1.4900 (-3.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar